Skip to main content
LYEL logo

LYEL · Lyell Immunopharma, Inc. · Held by Funds

Track LYEL — free
$9.70 +0.90 (+10.23%) At close · Oct 20
Market Cap
$215.65M
Shares
24.51M
Volume · Oct 20 158.62K Avg daily vol (3M) 154.08K

Registered funds — mutual funds, ETFs and closed-end funds — whose latest Form N-PORT portfolio report holds this exact listed security, matched by CUSIP. Each row is one fund position with its size, value and weight in that fund.

Fund Ownership of LYEL by Fund Type

Registered funds' Form N-PORT reports for the quarter ended Jun 30, 2026

Index funds and index ETFs hold 6.20% of shares outstanding.

Fund type Of shares outstanding Shares
Index funds 0.97% 238,076
Index ETFs 5.22% 1,280,314
Active ETFs 0.06% 15,598
Active funds 0.43% 105,131
Unclassified 0.10% 23,351
All registered funds 6.78% 1,662,470
How fund types are measured

Each fund series counts once, with its latest Form N-PORT report dated inside the quarter; only long share positions count, restated to today's split basis. The fund type is the series' latest Form N-CEN answer on or before the quarter end (the index-fund box and the exchange-traded flag), never its name. Unclassified funds have no usable N-CEN; unit investment trusts are among them, so index ownership is a floor. Funds sit inside their advisers' 13F reports, so these shares overlap the 13F figures and are never added to them.

Funds holding LYEL

88 fund positions
Fund Balance Value % of Fund Open
Showing 1–50 of 88 positions
Key facts CIK 1806952 CUSIP 55083R203 13F (30d) 7 filings 7 filers Visit website Investor relations